Home
About
Overview
Sharing Data
ORCID
Help
History (1)
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story. Exp Gerontol. 2015 Aug; 68:51-8.
View in:
PubMed
subject areas
Alzheimer Disease
Alzheimer Disease
Animals
Animals
Autophagy
Autophagy
Behavior, Animal
Behavior, Animal
Cerebrovascular Circulation
Cerebrovascular Circulation
Cognition Disorders
Cognition Disorders
Disease Models, Animal
Disease Models, Animal
Longevity
Longevity
Memory Disorders
Memory Disorders
Mice
Mice
Neurofibrillary Tangles
Neurofibrillary Tangles
Plaque, Amyloid
Plaque, Amyloid
Sirolimus
Sirolimus
TOR Serine-Threonine Kinases
TOR Serine-Threonine Kinases
Vasodilator Agents
Vasodilator Agents
authors with profiles
Arlan G. Richardson